Skip to main content

Articles

Page 12 of 14

  25. Retail drug sellers are a major source of health care and medicines in many countries. In Tanzania, drug shops are widely used, particularly in rural and underserved areas. Previously, the shops were allowed t...

    Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:23
    Content type: Policy analysis Published on:

    The Erratum to this article has been published in Journal of Pharmaceutical Policy and Practice 2015 8:29

  26. Nunavut is an Arctic territory in Canada subject to many social, economic and health disparities in comparison to the rest of the nation. The territory is affected by health care provision challenges caused by...

    Authors: Sandra J. Romain, Jillian C. Kohler and Kue Young
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:22
    Content type: Research Published on:

  29. In 2007, the Sixtieth World Health Assembly (WHA) passed a resolution entitled “Better medicines for children” and subsequently the World Health Organization (WHO) recommended the inclusion of child-appropriat...

    Authors: Xavier Nsabagasani, Ebba Hansen, Anthony Mbonye, Freddie Ssengooba, Herbert Muyinda, James Mugisha and Jasper Ogwal-Okeng
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:19
    Content type: Research article Published on:

  30. The purpose of this study is to describe trends in the utilization of antihypertensive medications, overall and by type of medication, specifically thiazide diuretics, as well as uncontrolled hypertension, in ...

    Authors: Rawan Saadeh, Dima Qato, Ali Khader, Yousef Shahin and Akihiro Seita
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:17
    Content type: Research article Published on:

  32. To explore the availability and utilization of the World Health Organization (WHO) recommended priority life-saving medicines for children under five in public health facilities in Uganda.

    Authors: Xavier Nsabagasani, Jasper Ogwal-Okeng, Anthony Mbonye, Freddie Ssengooba, Simon Muhumuza and Ebba Holme Hansen
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:18
    Content type: Research article Published on:

  33. Taiwan’s National Health Insurance (NHI) has encouraged physicians to use “chronic medication prescriptions” for patients with stable chronic diseases since 1995. Patients are allowed to refill such prescripti...

    Authors: Jason C Hsu, Dennis Ross-Degnan, Anita K Wagner, Ching-Lan Cheng, Yea-Huei Kao Yang, Fang Zhang and Christine Y Lu
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:15
    Content type: Research article Published on:

  34. In the management of HIV infection, tenofovir is preferred to its predecessors – zidovudine and stavudine – in the antiretroviral therapy (ART) nucleoside backbone. Tenofovir’s (TDF) preference is based on its...

    Authors: Francis Kalemeera, Assegid T Mengistu and Johannes Gaeseb
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:14
    Content type: Research article Published on:

  35. Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to...

    Authors: Gildas Agodokpessi, Nadia Aït-Khaled, Martin Gninafon, Leon Tawo, Wilfried Bekou, Christophe Perrin, Karen Bissell, Nils Billo, Donald A Enarson and Chen-Yuan Chiang
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:12
    Content type: Research article Published on:

  36. Tanzania suffers a severe shortage of pharmaceutical staff. This negatively affects the provision of pharmaceutical services and access to medicines, particularly in rural areas. Task shifting has been propose...

    Authors: Karin A Wiedenmayer, Ntuli Kapologwe, James Charles, Fiona Chilunda and Siana Mapunjo
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:13
    Content type: Research article Published on:

  37. Generic medicine prescribing has become a common practice in public hospitals. However, the trend in private medical centres seems to be different. The objective of this study was to investigate knowledge, per...

    Authors: Rohit Kumar, Mohamed Azmi Hassali, Fahad Saleem, Alian A Alrasheedy, Navneet Kaur, Zhi Yen Wong and Muhamad Ali SK Abdul Kader
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:11
    Content type: Research article Published on:

  38. The Brazilian constitution guarantees the right to health, including access to medicines. In May 2004, Brazil’s government announced the “Farmácia Popular” Program (FPP) as a new mechanism to improve the Brazilia...

    Authors: Isabel Cristina Martins Emmerick, José Miguel do Nascimento Jr, Marco Aurélio Pereira, Vera Lucia Luiza and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:10
    Content type: Research article Published on:

  39. Pharmaceutical supply chain is a significant component of the health system in supplying medicines, particularly in countries where main drugs are provided by local pharmaceutical companies. No previous studie...

    Authors: Mona Jaberidoost, Laya Olfat, Alireza Hosseini, Abbas Kebriaeezadeh, Mohammad Abdollahi, Mahdi Alaeddini and Rassoul Dinarvand
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:9
    Content type: Research article Published on:

  41. New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: B...

    Authors: Christine Y Lu, Isabel Cristina M Emmerick, Peter Stephens, Dennis Ross-Degnan and Anita K Wagner
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:7
    Content type: Research Published on:

  42. Patient access (or risk-sharing) schemes are alternative market access agreements between healthcare payers and medical product manufacturers for conditional coverage of promising health technologies. This stu...

    Authors: Christine Y Lu, Caitlin Lupton, Shana Rakowsky, Zaheer-Ud-Din Babar, Dennis Ross-Degnan and Anita K Wagner
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:6
    Content type: Research article Published on:

  45. A key policy question for the government of Uganda is how to equitably allocate primary health care pharmaceutical budgets to districts. This paper seeks to identify variables influencing current primary healt...

    Authors: Paschal N Mujasi and Jaume Puig-Junoy
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:3
    Content type: Research article Published on:

  46. In 2007, the World Health Organization (WHO) launched the ‘make medicines child size’ (MMCS) campaign by urging countries to prioritize procurement of medicines with appropriate strengths for children’s age an...

    Authors: Xavier Nsabagasani, Jasper Ogwal-Okeng, Anthony Mbonye, Freddie Ssengooba, Rebecca Nantanda, Herbert Muyinda and Ebba Holme Hansen
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:2
    Content type: Research article Published on:

  47. To evaluate the determinants of compliance with national policies recommending Artemisinin Combination Therapy (ACT) for the treatment of uncomplicated malaria in the community.

    Authors: Catherine E Vialle-Valentin, Robert F LeCates, Fang Zhang and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:1
    Content type: Research article Published on:

  50. Authors: Alexis Heaton, Amanda Ombeva, Deogratias Leopold, Golbert Kazoza, Patrick Nganji, Cathy Mugeni, Megan Noel and Yasmin Chandani
    Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P11
    Content type: Poster presentation Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us